Change in anti-KLH IgG antibody response to two vaccinations of KLH in nonatopic participants At baseline and Day 47 [clinicaltrials_resource:06d64ad3b115357dd9a09c8e368e8736]
Participants will receive a total of two 100 mcg intradermal (ID) KLH immunizations with 1 mg/ml KLH per immunization. Immunizations will be given 21 days apart at Visits 5 and 6.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change in anti-KLH IgG antibody response to two vaccinations of KLH in nonatopic participants At baseline and Day 47 [clinicaltrials_resource:06d64ad3b115357dd9a09c8e368e8736]
Participants will receive a total of two 100 mcg intradermal (ID) KLH immunizations with 1 mg/ml KLH per immunization. Immunizations will be given 21 days apart at Visits 5 and 6.
Bio2RDF identifier
06d64ad3b115357dd9a09c8e368e8736
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:06d64ad3b115357dd9a09c8e368e8736
measure [clinicaltrials_vocabulary:measure]
Change in anti-KLH IgG antibod ...... KLH in nonatopic participants
time frame [clinicaltrials_vocabulary:time-frame]
At baseline and Day 47
description
Participants will receive a to ...... days apart at Visits 5 and 6.
identifier
clinicaltrials_resource:06d64ad3b115357dd9a09c8e368e8736
title
Change in anti-KLH IgG antibod ...... cipants At baseline and Day 47
@en
type
label
Change in anti-KLH IgG antibod ...... 64ad3b115357dd9a09c8e368e8736]
@en